calendar

355 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 108 grant

★ save view export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

show past →

sort

soonest latest type sponsor alpha

type: approval type: device pma type: earnings clear all

approval

78

phase 1 completion73

phase 2 initiation62

pdufa48

therapy area

no tagged catalysts yet

Week of Aug 3, 2026

1

Aug 7, 2026earnings26dANI PHARMACEUTICALS INC earningsANI PHARMACEUTICALS INC

Anticipated earnings call for ANI PHARMACEUTICALS INC ($ANIP).

full page →yahoo earnings ↗

Week of Aug 10, 2026

1

Aug 12, 2026earnings31dPolyPid Ltd. earningsPolyPid Ltd.

Anticipated earnings call for PolyPid Ltd. ($PYPD).

full page →yahoo earnings ↗

Week of Aug 17, 2026

1

Aug 18, 2026earnings37dMedtronic plc earningsMedtronic plc

Anticipated earnings call for Medtronic plc ($MDT).

full page →yahoo earnings ↗

Date TBD

2

TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗

TBDapproval

← prev

page 8 of 8

next →

TRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →OXCARBAZEPINE →fda approvals ↗

$ANIP81.98-2.15%

$MDT83.87+1.80%

$ABBV248.13-0.71%

$PYPD5.2300-3.51%

$NVS154.05-0.37%